Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wockhardt Ltd slips for fifth straight session
Wockhardt Ltd is quoting at Rs 1936.7, down 0.67% on the day as on 13:19 IST on the NSE. The stock jumped 87.69% in last one year as compared to a 6.32% slide in NIFTY and a 15.05% spurt in the Nifty Pharma index.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Cipla Ltd soars 2.53%, up for fifth straight session
Cipla Ltd is quoting at Rs 1476.6, up 2.53% on the day as on 12:44 IST on the NSE. The stock is down 1.95% in last one year as compared to a 6.16% drop in NIFTY and a 14.71% drop in the Nifty Pharma.
Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%
In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%
Indian stock markets traded mixed on Monday, with Sensex dipping slightly and Nifty inching higher amidst rising oil prices due to Iran-US tensions. While some blue-chips gained, broader markets saw a minor decline. Analysts suggest a potential market upturn due to easing FII selling and South Korea's volatility, but a deficient monsoon remains a concern. Upcoming Q1 results are expected to drive stock-specific movements.
Health ministry issues proposal for one-year residual shelf life for imported drugs
The Union Health Ministry is proposing to relax import rules for medicines, requiring a minimum 12-month shelf life upon arrival instead of the current 60% of total shelf life. This move aims to simplify business operations and ensure medicine availability. The change, however, will not affect specialized drugs like biologicals and radiopharmaceuticals. Officials believe this will cut down wastage and improve inventory management, ultimately benefiting patients.
Rajesh Palviya of Axis Sec suggests JSW Infrastructure, Ind-Swift Laboratories, Welspun Living shares to buy next week
The Indian stock market will remain closed on June 26 for the Muharram holiday. Benchmark indices extended their winning streak ahead of the holiday, with Nifty 50 closing at 24,056 and Sensex at 77,100.47, boosted by easing crude oil prices and supportive measures for the rupee.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War Levels - NDTV
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War LevelsNDTVSensex Today | Stock Market Live: Nifty at 24,200, Sensex up 550 pts; IndiGo, Max Healthcare, Maruti Suzuki top gainersMoneycontrol.comStock Market Today Live, June 25: Nifty holds above 24,100, Sensex rises 500 pts led by auto, healthcare stocksBusinessLine
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 June - Mint
Stocks to buy or sell: Osho Krishan of Angel One suggests buying HDFC Bank, Emcure Pharma shares on 25 JuneMint
Stocks to buy: Aurobindo Pharma, Delhivery, Ather Energy, says Ajit Mishra
Market outlook by Ajit Mishra: The analyst from Religare Broking expects Nifty to consolidate in the near-term; among stocks he recommends Delhivery, Ather Energy and Aurobindo Pharma.
Ipca Laboratories Ltd spurts 0.16%, up for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1627.6, up 0.16% on the day as on 12:44 IST on the NSE. The stock is up 19.88% in last one year as compared to a 4.96% jump in NIFTY and a 15.12% jump in the Nifty Pharma.